Alto Neuroscience Inc. (ANRO)
NYSE: ANRO
· Real-Time Price · USD
3.37
0.23 (7.32%)
At close: Aug 18, 2025, 2:48 PM
Alto Neuroscience Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Cash & Equivalents | 147.59M | 160.75M | 168.23M | 181.7M | 193.12M | 205.9M | 82.55M | 51.29M | -48.34M | 48.34M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 96.69M | n/a |
Long-Term Investments | n/a | 500K | 500K | 500K | 500K | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.07M | 569K | 4K | 4K | 4K | 58K | 131K | 201K | -48.34M | 55K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | 8K | 8K | n/a | 546K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.26M | 23K | 30K | 277K | 148K | 150K | 2.31M | 117K | n/a | n/a |
Total Current Assets | 149.85M | 163.52M | 169.34M | 183.53M | 195.41M | 208.31M | 85.39M | 52.05M | 48.34M | 49.22M |
Property-Plant & Equipment | 6.96M | 7.32M | 7.7M | 7.58M | 1.44M | 1.55M | 1.11M | 987K | n/a | 1.58M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 8.03M | 8.39M | 8.21M | 8.08M | 1.95M | 1.61M | 1.24M | 1.19M | -48.34M | 1.63M |
Total Assets | 157.88M | 171.91M | 177.54M | 191.61M | 197.36M | 209.92M | 86.63M | 53.24M | n/a | 50.85M |
Account Payables | 1.67M | 1.38M | 1.58M | 2.25M | 1.84M | 2.41M | 1.07M | 1.76M | n/a | 1.61M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.84M | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 3.53M | 2.32M | 1.15M | 125K | n/a | n/a | n/a |
Other Current Liabilities | 8.13M | n/a | 2.61M | n/a | n/a | 2.79M | 3.77M | -3.66M | n/a | 3.54M |
Total Current Liabilities | 8.13M | 7.26M | 10.01M | 14.02M | 9.84M | 8.01M | 5.61M | 5.98M | n/a | 5.56M |
Long-Term Debt | 4.21M | 21.15M | 11.56M | 7.92M | 7.74M | 8.81M | 151.34M | 9.76M | n/a | 81.7M |
Other Long-Term Liabilities | 22.12M | n/a | n/a | n/a | n/a | n/a | 1.35M | 98.6M | n/a | 1.88M |
Total Long-Term Liabilities | 26.34M | 25.56M | 16.07M | 12.54M | 7.74M | 8.81M | 152.69M | 108.35M | n/a | 83.7M |
Total Liabilities | 34.47M | 32.82M | 26.08M | 26.56M | 17.58M | 16.82M | 158.3M | 114.33M | n/a | 89.26M |
Total Debt | 4.21M | 26.44M | 16.94M | 16.79M | 10.06M | 10.01M | 151.46M | 9.95M | n/a | 82.11M |
Common Stock | 3K | 3K | 3K | 3K | 3K | 3K | n/a | 1K | n/a | 1K |
Retained Earnings | -171.27M | -153.56M | -138.4M | -123.19M | -106.41M | -90.38M | -76.97M | -65.75M | n/a | -40.66M |
Comprehensive Income | 31K | 14K | -101K | -95K | -89K | -84K | -79K | -86K | -38.41M | -46K |
Shareholders Equity | 123.41M | 139.1M | 151.46M | 165.05M | 179.78M | 193.1M | -71.67M | -61.1M | 35.71M | -38.41M |
Total Investments | n/a | 500K | 500K | 500K | 500K | n/a | n/a | n/a | 96.69M | n/a |